Steven Cohen’s Pharvaris PHVS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$92M Buy
2,899,767
+1,258,567
+77% +$44.1M 0.1% 230
2026
Q2
$56.8M Buy
1,641,200
+634,184
+63% +$19.2M 0.06% 386
2026
Q1
$28.4M Buy
1,007,016
+295,391
+42% +$7.89M 0.04% 635
2025
Q4
$19.7M Buy
711,625
+192,244
+37% +$4.63M 0.02% 904
2025
Q3
$13M Buy
519,381
+481,769
+1,281% +$10.7M 0.02% 704
2025
Q2
$662K Sell
37,612
-14,962
-28% -$241K ﹤0.01% 1696
2025
Q1
$825K Buy
52,574
+44,653
+564% +$753K ﹤0.01% 1493
2024
Q4
$152K Buy
+7,921
New +$163K ﹤0.01% 1929

Other funds holding PHVS

Steven Cohen's PHVS Position: Q3 2026 in Review

Steven Cohen increased its Pharvaris (PHVS) stake by 77% in Q3 2026, buying an estimated $44.1M and bringing the position to 2,899,767 shares worth $92M. The position accounts for 0.1% of the portfolio, ranked #230.

Steven Cohen first reported a position in PHVS in Q4 2024 and has held it in 8 quarters since. 135 funds tracked by Wall St. Rank hold PHVS as of Q3 2026.

  • Steven Cohen held 2,899,767 shares of Pharvaris worth $92M as of Q3 2026.
  • Steven Cohen bought 1,258,567 Pharvaris shares in Q3 2026, an estimated $44.1M.
  • Pharvaris made up 0.1% of Steven Cohen's portfolio in Q3 2026, its #230 holding.
  • Steven Cohen first reported a position in Pharvaris in Q4 2024 and has held it in 8 quarters since.
  • 135 funds tracked by Wall St. Rank held Pharvaris as of Q3 2026.

Based on Point72 Asset Management's 13F filing for Q3 2026, filed 16 Nov 2026.